PR Newswire
03 Jan 2023, 20:55 GMT+10
![]() |
MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum (NIF). The forum is taking place Sunday, January 8, 2022, as part of the activities surrounding the annual J.P. Morgan Healthcare Conference.
At the conference, Dr. Stamler will be featured on a panel entitled, "New Approaches to Parkinson's and Movement Disorders." He will also present a company update and participate in investor and business development meetings.
The program for the 6th Annual NIF is designed to cover the latest developments in global bio-partnering and investment, with additional panels covering scientific advances in key therapeutic areas of neurodegenerative diseases and CNS more broadly, which includes neuropsychiatry, ophthalmology, neurotech and digital therapeutics.
About Alterity Therapeutics Limited
Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company's lead asset, ATH434, has the potential to treat various Parkinsonian disorders. Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company's web site at www.alteritytherapeutics.com.
Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.
Get a daily dose of Malaysia Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.
More InformationKUALA LUMPUR, Malaysia: Airbus is in discussions with Malaysian airlines to introduce its A220 aircraft, the company's Asia-Pacific...
WASHINGTON, D.C.: Families of some of the 346 people who died in two deadly Boeing 737 MAX crashes plan to oppose a proposed deal between...
BANGKOK, Thailand: An American political science teacher, Paul Chambers, is still stuck in Thailand, even though the government dropped...
KATHMANDU, Nepal: An Indian climber and a Filipino climber were the first to die on Mount Everest during the current climbing season...
ALMATY, Tajikistan: Tajikistan has officially removed criminal liability for liking social media posts that the government deems extremist,...
For decades, the US Agency for International Development (USAID) has been vital in combating HIV across the Asia–Pacific region, where...
KUALA LUMPUR, Malaysia: Airbus is in discussions with Malaysian airlines to introduce its A220 aircraft, the company's Asia-Pacific...
BEIJING, China: Huawei has launched its first laptops running on its proprietary HarmonyOS, marking a significant step in its effort...
NEW YORK, New York: U.S. stocks dived on Wednesday as investors and traders fretted about the passing of the budget bill by Congress...
WASHINGTON, D.C.: U.S. President Donald Trump said over the weekend that Walmart should eat the tariffs instead of blaming duties imposed...
WASHINGTON, D.C.: The Trump administration is scrutinizing Apple's plans to partner with Chinese tech giant Alibaba to bring its artificial...
TOKYO, Japan: Nissan is reportedly considering shutting down two car assembly plants in Japan and several overseas factories, including...